Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-14

Clinical Trial Update: Retinyl Palmitate-loaded Ethosomes in Acne Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of retinyl palmitate-loaded ethosomes for facial acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Retinyl palmitate-loaded ethosomes (retinyl palmitate-loaded ethosomes)

Snippet

Sponsor: Assiut University | Conditions: Facial Acne Vulgaris | Phase 2 | Status: COMPLETED